2022-07-11
Recently, the third China Traditional Chinese Medicine Brand Building Conference released the 2022 annual 8 brands in the traditional Chinese medicine industry, and Shanghai Huanghai Pharmaceutical Company, a wholly-owned subsidiary of Shanghai Sundise Traditional Chinese Medicine Co., Ltd, was listed on the TOP100 proprietary Chinese medicine enterprises for the first time.
+
2022-06-24
Sunside Yifeng Pan： Fight the epidemic, shoulder the task till the future
For Chinese medicine enterprises, this year is destined to be an extraordinary year, facing multiple pressures such as the economic downturn in the post-epidemic era, the poor circulation of the industrial chain, and the reform of the pharmaceutical system, but in another word, company also ushered in the strong support of relevant national policies and the increase of industrial attention.
+
2018-04-27
Shanghai Traditional Chinese Medicine Industry Association 7th general assembly
On the afternoon of April 27, the first Council and supervisory board meeting of the seventh session of Shanghai Chinese Medicine Industry Association were held in the International conference Hall of Shanghai Science Hall. All the directors and members of the association attended the meeting.
+
2017-11-14
On November 7, 2017, the 19th China International Industry Expo with the theme of "Innovation, intelligence and Green" opened at the National Convention and Exhibition Center in Shanghai. At the strong invitation of the Shanghai Science and Technology Commission, Shanghai Sundise Traditional Chinese Medicine Co., Ltd. actively settled the company's innovative product of Fuzheng Huayu in the "New Drug research and development" section of the "Innovation Science and Technology Museum", so that all walks of life more fully understand Shanghai Sundise Traditional Chinese Medicine Co., Ltd. 's innovative traditional Chinese medicine Fuzheng Huayu. Fuzheng Huayu is a Chinese patent medicine recommended by professional doctors in the field of anti-liver fibrosis. Clinical trials have proved that it can effectively improve chronic hepatitis B liver fibrosis, with a reversal rate of liver fibrosis of 52% and a total effective rate of 74.1% for improving liver function. The exhibition made the community further understand the product of Fuzheng Huayu. During the exhibition, Fu Guoqing, chief engineer of the Municipal Science and Technology Commission, and Qin Wenbo, deputy director of the Municipal Science and Technology Commission, visited the booth of Fuzheng Huayu and fully affirmed the product. In addition, there are more new medical products on display in this section, showing the current new medical technology for the audience.
+
2017-01-23
Shanghai Pharmaceutical Industry Association in accordance with the "Shanghai Pharmaceutical Industry Famous Product recommendation and Evaluation Measures", after the initial review and industry expert group review, and finally approved by the Shanghai Pharmaceutical Industry Association famous product certification Committee.
+
2017-01-09
Huanghai Pharmaceutical Company was rated as a five-star enterprise with social responsibility
From July to October 2016, under the guidance of the Ministry of Industry and Information Technology, the China Federation of Industrial Economics organized the "2016 Third Chinese Industrial Enterprise Performance star Evaluation" activity. Activities in accordance with the management and implementation measures issued by the Federation of Industry and Commerce, after review, preliminary evaluation, review, relevant departments to solicit opinions, publicity and other procedures, produced the "2016 third China Industrial Enterprise performance star List", in the national social responsibility report of thousands of enterprises, awarded 52 enterprises "China's industrial industry to fulfill social responsibility five-star enterprises (2016)" title, Shanghai Huanghai Pharmaceutical Co., LTD., a subsidiary of Shanghai Sundise Traditional Chinese Medicine Co., Ltd, was evaluated as a "Five-star Enterprise for Social Responsibility in China's Industrial Sector (2016)". Guided by the new development concept, we take sustainable development as our mission, actively carry out social responsibility practice, and make positive efforts in terms of responsibility and initiative innovation. In the future, we will continue to work on social responsibility and write a blueprint for sustainable development!
+
2016-07-27
On July 22, 2016, Fuzheng Huayu capsule, a compound traditional Chinese medicine independently developed by the company for the treatment of liver fibrosis, was approved by the State Food and Drug Administration (No. 125 in 2016) and became a national secondary protection variety of traditional Chinese medicine.
+
2016-07-20
In July, sponsored by the Shanghai Pharmaceutical Industry Association, the theme of the first half month of Shanghai Medicine in July was "Research progress of anti-fibrosis and its proprietary Chinese medicine Fuzheng Huayu preparation". The cover figure Professor Liu Ping is one of the founders of Fuzheng Huayu Prescription. This magazine focuses on the research progress of traditional Chinese medicine in the treatment of major diseases, the main mechanism and clinical efficacy of Fuzheng Huayu prescription against liver fibrosis, the identification method of the main components of Fuzheng Huayu prescription and the quality research of the active ingredients, and the whole process information monitoring system of Fuzheng Huayu product production. It fully demonstrates the complete industrial chain of Fuzheng Huayu prescription from research and development, production to quality control.
+
2016-06-28
Huanghai Pharmaceutical Company 2015 annual social responsibility report released
On June 26, "Responsibility leads Innovation, Management Drives Development - 2016 China Industrial Corporate Social Responsibility Report Conference" was held at the National Convention Center. The conference was hosted by the China Federation of Industry and Economy, the National Development and Reform Commission, the Ministry of Industry and Information Technology, the Ministry of Human Resources and Social Security, the Ministry of Environmental Protection, the State-owned Assets Supervision and Administration Commission of the State Council, the General Administration of Quality Inspection, the State Administration of Work Safety and other relevant departments under the guidance of The State Council, China coal, machinery, steel, petrochemical, light industry, textile, building materials, nonferrous metals and power, total nine national industry associations (federations) co-organized. Li Yizhong, Vice director of the Economic Committee of the CPPCC National Committee, President of the China Federation of Industry and Economy, Feng Fei, Vice Minister of the Ministry of Industry and Information Technology, Li Zhaoqian, deputy director of the State Administration of Work Safety and other leaders attended the meeting. Mr. Adjani, Representative Office of the United Nations Industrial Development Organization in China, attended the meeting and delivered a speech.
+